NCT00454233View on ClinicalTrials.gov

A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

97

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

YM543

Oral

DRUG

Metformin

Oral

DRUG

Placebo

oral

Trial Locations (6)

Unknown

4 Sites, Moscow

Nizhny Novgorod

Petrozavodsk

10 Sites, Saint Petersburg

Samara

Yekaterinburg

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY